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ORIGINAL ARTICLE
Patients’ views on follow up of colorectal cancer:
implications for risk communication and decision making
S Papagrigoriadis, B Heyman
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Background: Medical views about the clinical value and potential detrimental effect on quality of life
of postoperative follow up are divided. There is no literature on the views of British patients with colo-
rectal cancer towards the follow up process.
Aim: To investigate patients’ views and experiences of follow up of colorectal cancer, and to assess
their attitudes towards suggested changes to follow up policy.
Patients and methods: A total of 156 asymptomatic and disease-free patients with colorectal cancer
were identified from the follow up clinic. Recurrence-free status was confirmed through retrieval of
computerised clinic letters. A postal survey using a 39 item piloted questionnaire was undertaken. Data
analysis generated descriptive statistics and logistic regression models.
Results: A response rate of 61% (95) was obtained. Among these respondents, 63% (60) had under-
gone initial surgery within three years of the time of the survey, and 86% (82) patients expected a fur-
ther follow up appointment. Majorities of the sample, ranging from 71% (67) to 96% (91), expressed
satisfaction with respect to clinic delays, staff conduct and knowledge about their case, consultation
time, and being able to discuss personal problems freely. However some patients reported difficulty in
discussing sexual problems at the clinic. Appointment imminence caused anxiety, sleep problems, and
decreased appetite in 35% (35), 27% (26), and 8 % (8) of patients respectively. However, 78% (74)
patients felt reassured and optimistic for the future after receiving results. Such optimism is not neces-
sarily justified in terms of estimated mortality risks. A majority (78%, 66) stated that they would value
finding out about the presence of recurrence even if there would be no survival benefit. Nearly half of
the sample (48%, 43) felt that they would disagree with the cessation of follow up in any circumstances.
Only 47% (42) and 27% (24) indicated that they would accept follow up by a specialist nurse or their
general practitioner, respectively. Attitude to follow up was unrelated to reported anxiety before
appointments. Only 22% (19) of the sample could identify risk indicators for recurrence, but 64% (61)
agreed that they would like to be told what to look for.
Discussion: A sample of patients with colorectal cancer expressed a high degree of satisfaction with
hospital follow up. Although a substantial minority reported suffering from pre-visit anxiety, most felt
that this disadvantage was compensated for by reassuring results, and believed that investigations did
not have a significant negative impact on their quality of life. Respondents valued hospital follow up,
and half would reject complete discharge or alternative forms of follow up. These findings demonstrate
that patients have a different perception of the risk of recurrence than clinicians who would consider
the survival prospects for most patients to be more or less unaffected by follow up interventions.
Attempted modifications to follow up policies should be introduced with caution, and should take
account of patient understanding of medical reasoning. The findings also raise questions about risk
communication with patients.
The clinical value of colorectal cancer follow up has beendebated for many years. Doubts have been expressed as towhether it results in increased survival.1 Complete
abandonment of follow up,2 and adoption of a “non-intensive”
follow up policy3 have been proposed. Audits in the UK and
other countries have shown that follow up practices vary
considerably.4 5 Surgeons who follow up their patients
intensively aim to detect early liver secondaries, which can be
treated surgically with good results.6 A recent meta-analysis
demonstrated a survival benefit for those patients who had
intensive follow up in which abdominal imaging and
carcinoembryonic antigen measurements were used.7
The argument of those who advocate abandonment of
follow up is twofold. Firstly, they argue that the often
extensive medical resources spent on follow up investigations
could be deployed more cost effectively in other areas of colo-
rectal cancer diagnosis and treatment.8 Secondly, they suggest
that secondary investigations may adversely affect patients’
quality of life, either through inducing anxiety or as a result of
the side effects of procedures such as colonoscopy, without
providing any compensating benefit in terms of reduced mor-
tality risks.
However the latter argument depends upon assumptions
about patient perspectives, about which little is known. The
one study found by the present authors, undertaken in
Holland,9 found no evidence that follow up reduced patients’
perceived quality of life. No studies of the views of British
patients have been published.
The present study had two aims: firstly, to investigate the
views and experiences of British patients with colorectal can-
cer about the follow up process; and, secondly, to assess their
attitudes towards abandoning hospital follow up, or substitut-
ing less medically intensive policies.
PATIENTS AND METHODS
Identification of the sample
Patients from the department of colorectal surgery were eligi-
ble to join the study if, at the time that data collection was
being carried out, they were being followed up after surgery
See end of article for
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for colorectal cancer and were considered free of recurrent
disease. All patients with colorectal cancer who had visited the
surgical outpatient department for follow up at least once
between April 1998 and April 1999, and whose clinical records
indicated that they were free of recurrence, were identified
through the hospital’s electronic records, and invited to
participate in the survey.
Questionnaire design
We decided to design our own questionnaire as there was no
existing tool which would have been adequate for our
purposes. Standardised quality of life measurement question-
naires were not considered appropriate as our patients were
asymptomatic, and any effect on their quality of life was
expected to occur intermittently, and soon after follow up
visits.
A 39 item questionnaire focused on the views and
experiences of patients about follow up visits and investiga-
tions. It was organised into six thematic sections covering,
from the patient’s perspective:
1. Clinical background.
2. Experience at the clinic.
3. Anxiety before the clinic visit.
4. Experience of investigations.
5. Attitude towards receiving information about the risk of
cancer recurrence.
6. Attitude towards possible changes in follow up policy.
Ethics committee approval was obtained. The questionnaire
was discussed with a focus group of experts (surgeons,
doctors, and health professionals specialising in colorectal
cancer treatment). It was then piloted with a small group of
patients who were probed about their answers so that their
comprehension of the questions could be checked.
Postal survey
Anonymous questionnaires were posted to 156 eligible
patients (see below) together with a covering letter and self
addressed stamped envelope. No reminders were sent on the
grounds that the questionnaire dealt with sensitive issues, and
that the risk of causing distress to the patients had to be mini-
mised.
Sampling and other methodological limitations of the study
will be reviewed in the discussion section.
RESULTS
The computer search identified 263 patients receiving follow
up for colorectal cancer from the department of general
surgery. Of those patients, 156 who were classified as currently
disease free were invited to participate in the study. A further
107 patients who had known or suspected recurrence were
excluded. The response rate was 60% (95). This relatively high
response rate for a single mail shot may reflect the importance
to patients of the services which they received. Only 7% (7)
respondents reported finding the questionnaire distressing,
and only one expressed regret at having completed it.
Descriptive statistics will be presented, unless indicated
otherwise, without adjustment for missing data. The (non-
significant) outcomes of logistic regression analyses will be
mentioned where appropriate.
Clinical background information
The majority of patients, 63% (60), had had surgery less than
three years before the study, and only 4% (4) had received sur-
gery more than five years before. Only 3% (3) of patients were
receiving adjuvant therapy at the time of the study. However
45% (43%) patients had received adjuvant therapy in the past.
A stoma was present at the time of the study in 21% (20) of
patients.
Experience in the clinic
Thirty patients (32%) reported that they mainly saw the con-
sultant at the clinic, while 10% (10) stated that they never saw
the consultant, and 35% (31) patients that they mainly saw
the junior doctors. Only 23% (21) patients saw the colorectal
nurse on follow up visits. A majority of the sample (82%, 76)
were confident that the doctors either knew all the details or
the essential facts of their case. However, 15% (14) patients
expressed disappointment that the doctors did not know
enough about their case.
Most respondents accepted having to wait at the clinic, as
61% (55) said that they did not mind delays, while 33% (30)
accepted them. The time spent with them during the consul-
tation was considered as long as they expected by 74% (68),
while another 19% (18) thought it was shorter than expected
but still adequate. Only 2% (2) patients thought that
consultations were too short.
Almost all of the patients sampled (97%, 91) felt that the
approach of staff in the clinic helped them to discuss their
problems, and 82% (76) considered themselves able to discuss
any problem at the clinic. However 12% (11) patients reported
difficulty in discussing problems, particularly those associated
with sexual dysfunction. Only 3% (3) indicated that they
would prefer to discuss such problems with their general
practitioner (GP) or a nurse rather than a hospital doctor.
Pre-visit anxiety and experience from investigations
Over half the sample (57%, 54) reported feeling no more anx-
ious than usual in the week before the follow up visit, and the
same proportion said that they did not have sleep problems.
However, 35% (35) admitted to feeling worried at this time.
Within the worried group, 91% (32) faced sleep problems and
23% (8) reduced appetite before an investigation.
Respondents were offered a choice of terms describing the
investigations to which they had already been submitted dur-
ing their follow up. Nearly half (46%, 44) described them as
“just necessary”, while 22% (21) found them unpleasant, 4%
(4) found them embarrassing, 6% (6) thought they were
painful, and 2% (2) wondered whether they were necessary.
Respondents were asked to select the investigation/
procedure they found most unpleasant. Almost half (45%, 43)
indicated that they didn’t mind any of the investigations. Only
27 responses to a specific question about the procedure that
patients found most unpleasant were received. From the
examinations/investigations listed, the most unpopular one
was digital rectal examination with rigid sigmoidoscopy,
which was thought to be the worst by 59% (16) of respondents
who mentioned a procedure. Only 11 other specific answers
were received. Colonoscopy was mentioned by four patients,
barium enema by three patients, and computed tomography,
faecal occult blood test, chest radiography, and examination
by the doctor by one patient in each case. Patients found a
procedure unpleasant either because it caused embarrass-
ment, mentioned by 18% (18), or caused pain, referred to by
6% (6) of respondents. Only 13% (12) of patients reported that
they worried while waiting for the results.
Attitude towards knowledge about recurrence
When patients were asked whether they would like to know
about the presence of recurrence even if there would be no
treatment or survival benefit, 77% (66) answered affirma-
tively. Only 17% (15) patients indicated that they would prefer
not to know if there would be no benefit from this knowledge.
Less than half of the sample (46%, 44) replied to a question
asking them why they wanted to know about their risk of
recurrence. Within this subsample, 41% (18) selected the
response “it is my right to know the extent of my disease”,
23% (10) wanted “to prepare psychologically”, 11% (5) “to
arrange family practical issues”, and one respondent “to
arrange work issues”. “Religious or spiritual reasons” was
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mentioned by one respondent. Non-specific responses were
given by 23% (10) of respondents answering this question
who agreed with the statement that they “just wanted to
know”.
Attitudes towards modifying follow up procedures
Respondents were asked how they might react in a hypotheti-
cal situation in which they would be discharged from follow
up with an assurance that there is no evidence that follow up
improves survival for patients with their condition. Almost
half of the sample (47%, 43) indicated that they would
disagree with the attempt to discharge them. A smaller group
(24%, 22) stated that they would agree, and 23% (21) were
willing to follow doctors’ recommendations.
When asked about alternative types of follow up, 46% (42)
stated that they would accept being followed up by a special-
ist nurse instead of a hospital doctor, while 32% (29) stated
that they would prefer to be seen by a hospital doctor. A fur-
ther 18% (17) expressed doubts about whether follow up by a
nurse would be as good as follow up by a hospital doctor. A
slightly lower proportion (26%, 24) expressed willingness to
accept a GP based follow up scheme than were willing to be
followed up by a specialist nurse, 13% (12) expressed doubts,
and 56% (51) said that they would refuse to accept this form
of follow up. However, when asked to choose between the
three forms of follow up mentioned above, 55% (53) opted for
the hospital doctor, 6% (6) the GP and 3% (3) the nurse, while
23% (22) said they were willing to follow the hospital doctor’s
recommendation, and 11% (12) did not answer the question.
Logistic regression was used to relate acceptance of
discharge from follow up to other aspects of a patient’s care,
including having previously undergone chemotherapy or
radiotherapy, the presence of a stoma, confidence in staff
knowledge, having had unpleasant experiences in the clinic
and anxiety before appointments. No statistically significant
relationships were found.
Knowledge about risk factors for recurrence
Overall, respondents showed little knowledge about risk
factors for recurrence. Only 21% (19) could name the
symptoms associated with cancer reappearing. However, a
majority would have liked to be informed about these matters,
with 64% (61) stating that they would like to learn what those
symptoms are.
DISCUSSION
The relatively low response rate, 60%, can be explained in
terms, firstly, of the decision not to send reminders to
non-respondents, a decision taken on account of the sensitiv-
ity of the subject matter; and, secondly, in terms of the known
pattern of low response rates to lengthy questionnaires10 by
older patients.11 Sample representativeness with respect to the
hospital population, therefore, cannot be assumed. For exam-
ple, patients who were motivated to continue their relation-
ship with the hospital may have been over-represented. In
addition, the views of a sample drawn from one hospital can-
not be taken as representative of wider populations on account
of possible regional variations and the influence of experi-
ences within one particular treatment milieu. Nevertheless,
the survey provides some indication of the views held by a
patient group who, for ethical reasons, must be approached
with sensitivity. The suggestive findings about the attractive-
ness to patients of hospital based follow up, and about their
lack of knowledge of their prospects or of risk factors are wor-
thy of replications which would test their generalisability.
The validity of questionnaire data must always be treated
with caution. Respondents may give responses that they
believe are expected, or may simply not know how they would
feel about a hypothetical situation—for example, about being
invited to withdraw from follow up.
The findings revealed considerable variability in the pattern
of follow up. According to our respondents, one third of follow
up was undertaken by junior doctors rather than consultants.
If hospitals are to provide a satisfactory service, they must
ensure that departmental guidelines on follow up policy are in
place for the junior doctors to follow. An unexpectedly low
number of our patients (23%) saw the colorectal specialist
nurse at their follow up visit in addition to a doctor. This low
provision of specialist nursing care reflects the recent history
of service organisation in the region, with colorectal cancer
treated by all general surgeons, while specialist nurses worked
mainly in colorectal clinics. There is still a shortage of
colorectal nurses in the region. Specialist nurses can provide
complementary advice that may contribute significantly to
quality of life—for example, in relation to sexual functioning
after cancer.12
Patient perception of the clinician’s knowledge of their case
significantly affects their trust in, and overall satisfaction
with, the follow up process. Our survey found that 82% of
patients were satisfied with this aspect of follow up.
Overbooking of clinics, with subsequent delays, unfortu-
nately, occurs all too frequently in the NHS, and often causes
patient dissatisfaction. Although patients who participated in
the present study commonly suffered such delays, most
expressed an accepting attitude towards them. This tolerance
may reflect the importance that patients place on follow up.
Patients attending clinics for less medically significant reasons
may be less accepting of delays than are those who have life
threatening conditions. A high degree of satisfaction may in
fact reflect low patient expectations. It is inappropriate for
cancer patients to be routinely referred to junior doctors for
assessment regardless of patients’ acceptance, particularly in
the absence of well defined protocols for assessment and
investigations. In our hospital a detailed protocol for follow up
of colorectal cancer is in practice in order to ensure that all
patients get equal quality of assessment regardless of the
grade of the clinician they see. Clinic delays are audited and an
effort is made to minimise them.
Follow up should address quality of life as well as survival,
and staff need to facilitate discussion of sensitive issues. Most
respondents (82%, 78) felt that they could discuss any
problem, although a few had found it difficult to discuss
sexual dysfunction. Clinicians should probe specifically for
sexual dysfunction problems, particularly after radical pelvic
surgery and radiotherapy. Impotence problems may be
reversed through the use of sildenafil.13 However, the social,
interpersonal, and psychological aspects of sexual recovery
after cancer surgery, as well as the impact on spouse relation-
ships, should also be considered, for example through
counselling by a specialist nurse, as noted above.
One of the arguments against intensive follow up for colo-
rectal cancer is that investigations have a negative impact on
the patient’s quality of life. However, as also found by Stiggel-
bout et al in Holland, patients being followed up do not report
a negative impact of investigations on their quality of life.9
Although about a third of respondents mentioned pre-visit
anxiety, this stress was compensated for by the reassuring
effect of negative investigations. The majority of patients
accept investigations stoically, perhaps believing that, al-
though sometimes embarrassing or unpleasant, they are nec-
essary. These findings suggest that a major benefit for patients
of intensive follow up procedures is the communication of
reassurance, a message which does not reflect the high
mortality risks they faced.
Another argument against intensive follow up is that there
is no point in knowing about recurrence if this knowledge will
not result in increased survival. Such knowledge may reduce
quality of life for patients whose mortality risk cannot be sig-
nificantly reduced by further medical interventions. Although
18% (15) of our respondents agreed with this argument, 77%
(66) desired to know about their condition and prospects, as
Patients’ views on follow up of colorectal cancer 405
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found elsewhere.14 It is worth noting that some patients
believed that they had a right to know the extent of their dis-
ease. On a more practical note, some patients wish to know
about their prospects in order to make family or work
arrangements, or to prepare psychologically.
Patients may approach health risk in a fundamentally
different way to health professionals who are attempting to
operationalise evidence based practice.15 Professionals focus
on probabilities induced from observation of aggregated
categories—for example, mortality risks in clinical subgroups
and the average reduction in these risks associated with follow
up. Patients and carers, in contrast, are primarily concerned
with the personal future of an individual whom epidemiology
treats as an average member of a category. They will, therefore,
seek any information which might indicate a favourable indi-
vidual trajectory.
The provision of investigations that may increase patients’
knowledge about their future enhances their autonomy16 even
where it does not improve their chance of survival. Health
economists who evaluate the cost of procedures against
reduced mortality risk may not take account of such intangi-
ble gains. The present findings support those of a previous
study which found that 92% of cancer patients want to have
access to all available information about their condition.17
The reactions to the hypothetical scenario of discharge from
follow up varied. Almost half (48%, 45) rejected this idea, 24%
(23) accepted it, and 23% (22) wanted clinicians to make the
decision. Logistic regression analysis failed to identify any
factors associated with this difference in attitude. During the
last 30 years, health services have become increasingly organ-
ised around screening programmes for cervical and breast
cancer, diabetes, chromosomal disorders, hypercholesterolae-
mia, and many other conditions. These programmes have
given rise to debates about whether screening may in some
cases be “over-sold”, as it is often not easy to demonstrate that
the benefits outweigh the costs, including risks associated
with the procedures themselves.18–20 Just as patients may hold
unrealistic expectations about the general benefits of screen-
ing, so colorectal cancer patients may not have been informed
about, or appreciated, the limited benefit, in terms of increased
survival chance, of follow up interventions. Our findings sug-
gest, however, that patients would still seek intensive follow
up even if they understood their limited average benefit.
When offered a direct choice between traditional hospital
based, specialist nurse and GP follow up, 56%, a clear majority,
opted for the existing system. Alternative follow up schemes
were more likely to be accepted if they were also hospital
based, with 46% (42) stating that they would accept follow up
by a specialist nurse, and only 26% (24) responding positively
to the idea of follow up by the GP. Although a GP based follow
up scheme has been tried for another cancer,21 and we have
previously found that 50% of GPs expressed willingness to
participate,22 the findings of this survey do not support this
policy. Patients may feel that GPs, because of their generalist
orientation, cannot maintain expert knowledge about particu-
lar conditions.
Nurse-led follow up clinics have already been established
for colorectal and other cancers,23 in other UK regions, since
they are viewed as more economical in terms of resources.
Although participants in the present study favoured the
system of hospital based follow up which they were familiar
with, they might respond favourably to a nurse-led system if
its rationale was explained to them in a way that addressed
their concerns and reasons for valuing follow up. Further
research exploring these issues in more depth from the
perspectives of patients and carers is needed.
The study found that 64% (61) of respondents stated that
they would like to know about symptoms suggestive of recur-
rence. In our hospital we have not followed a policy of provid-
ing detailed information to patients on symptoms of
recurrence. This is because symptoms of recurrence are
non-specific, and information might cause anxiety. However,
it can be argued that if we provided written information about
suspicious symptoms, a small number of recurrences occur-
ring during long intervals between annual appointments
could be detected as a result of patient self reporting. This
potential theoretical benefit should be balanced against the
risk of generating excessive anxiety and unnecessary appoint-
ments.
Logistic regression analysis did not reveal any clinical
factors that affect the patients’s views. Patients of all stages
that had a curative resection also had the same protocol of
investigations. Previous chemotherapy and radiotherapy
(associated with Dukes’s C stage of disease) did not affect the
attitude towards follow up.
In conclusion our findings confirm that British patients
with colorectal cancer show a positive attitude, if not an
attachment, towards the follow up process. Our study
supports the findings of other studies that, although a small
degree of pre-visit anxiety is generated, follow up provides
reassurance for patients and generates optimism that may,
however, not be justified by the existing evidence. Investiga-
tions are well tolerated and there is a high degree of satisfac-
tion from the whole process. There is considerable resistance
to proposals about either abandoning or modifying the exist-
ing follow up policy. Any attempts to do so should be based on
better understanding of the perspectives of patients.
. . . . . . . . . . . . . . . . . . . . .
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